TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SYK

Stryker Corporation

Healthcare · Medical Devices

274.20$ -0.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Stryker Corporation (SYK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 6,589 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SYK
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
4,909 5,815 5,243 5,422 5,494 6,436 5,866 6,022 6,057 7,171 6,020 6,589 25,837
1,889 2,261 2,049 2,098 2,101 2,447 2,186 2,272 2,205 2,494 2,210 2,091 9,000
3,020 3,554 3,194 3,324 3,393 3,989 3,680 3,750 3,852 4,677 3,810 4,498 16,837
335 328 356 352 364 342 393 396 410 401 413 434 1,658
1,701 1,941 1,840 1,847 1,896 2,102 2,300 1,993 2,045 2,135 2,281 2,229 8,690
2,029 2,129 2,191 2,166 2,185 2,326 2,501 2,389 2,717 2,716 2,874 2,839 11,146
991 1,425 1,003 1,158 1,208 1,663 1,179 1,361 1,135 1,961 936 1,659 5,691
137 159 157 381 148 141 827
869 1,226 923 998 1,043 528 764 1,016 1,029 1,705 850 1,564 5,148
177 83 135 173 209 -18 110 132 170 856 105 288 1,419
692 1,143 788 825 834 546 654 884 859 849 745 1,276 3,729
1,131 1,476 1,183 1,256 1,311 792 1,036 1,471 1,363 2,030 1,298 1,564 6,255

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?